Insomnia represents a pervasive global health challenge characterized by persistent difficulty falling asleep, staying asleep, or experiencing restorative sleep. ATANG's CES (Cranial Electrotherapy Stimulation) Sleep Aid Series presents a scientifically-validated, non-pharmacological insomnia remedy that operates through neuromodulation principles. This advanced technology delivers precise microcurrents through cranial electrodes, targeting key neural pathways involved in sleep-wake regulation. The mechanism involves gentle stimulation of the hypothalamus and limbic system, promoting alpha brainwave production while simultaneously reducing cortisol levels and sympathetic nervous system activity. Clinical studies conducted across multiple research institutions demonstrate significant improvements in polysomnographic parameters, including reduced sleep latency by approximately 35%, decreased wake after sleep onset (WASO) by 42%, and increased total sleep time by nearly 28%. The device incorporates proprietary waveform technology that adapts to individual physiological responses, ensuring optimal therapeutic dosage. Manufacturing standards include ISO 13485 certification with FDA registration (3015515517) and CE marking under Medical Device Directive 93/42/EEC. Application protocols recommend usage during pre-sleep routines for 20-40 minutes, with clinical evidence showing cumulative benefits over 4-6 weeks of consistent application. Real-world case documentation includes a multicenter observational study involving 150 participants with chronic primary insomnia, where 78% achieved clinically significant improvement in Pittsburgh Sleep Quality Index scores. The device features intelligent safety mechanisms including automatic current regulation, session timers, and impedance monitoring. For comprehensive technical specifications, clinical evidence documentation, and personalized usage protocols, we invite healthcare professionals and distributors to contact our technical support team for detailed consultation.